References

NAG kit

Yuen, C-T, Price, R G, Richardson, A C and Praill, P F G (1981)

The assay of arylsterase in serum using two new colorimetric substrates, w-nitrostyrylacetate and propionate. Clin. Chim. Acta 112, 99-105.

Yuen, C-T, Price, R G, Chattagoon, L, Richardson, A C and Praill, P F G (1982)

Colorimetric assays for N-acetyl-ß-D-glucosaminidase and ß-D-galactosidase in human urine using newly-developed w-nitrostyryl substrates. Clin. Chim. Acta 124, 195-204.

Yuen, C-T, Kind, P R N, Price, R G, Praill, P F G and Richardson, A C (1984)

Colorimetric assay for N-acetyl-ß-glucosaminidase (NAG) in pathological urine using the w-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Ann. Clin. Biochem. 21, 295-300.

Taylor, S A, Richardson, A C, Praill, P F G and Price, R G (1990)

A new colorimetric kit for the assay of N-acetyl-ß-glucosaminidase in urine. Clin Chem News, 16, 24-26.

Price R G (1992)

The role of NAG (N-acetyl-ß-D-glucosaminidase) in the Diagnosis of kidney Disease including the monitoring of Nephrotoxicity. Clin. Nephrology, 38, Suppl. 1, S14-S19.

Price R G (1992)

The measurement of Urinary N-acetyl-ß-D-glucosaminidase (NAG) and its isoenzymes, Methods and Clinical Applications. Eur.J.Clin.Chem.Clin.Biochem., 30, 693-705.

Price, R.G. (1991)

New colorimetric substrates for the assay of hydrolytic enzymes: N-acetyl-ß-D-glucosaminidase (NAG) - an improved test for the assessment of renal disease. A Review. CHEMISTRY TODAY (CHIMMICA oggi), 6, 15-19.

Mueller P W, Price R G and Porter G A. (1997)

Urinary biomarkers to Detect significant Effects of environmental and Occupational Exposure to Nephrotoxins - Overview. Renal Failure, 19 (4), 501-504. [PAJ]

Pocsi I, Csathy L, Olah V A and Price R G (1992)

Assay of N-acetyl-ß-D-glucosaminidase in urine from neonate: comparison of two new colorimetric methods using MNP-GlcNAc and VRA-GlcNAc as substrates. Ann Clin. Biochem. 29, 292-295. [PAJ]

Posci, I., Taylor, S.A., Richardson, A.C., Aamlid, K.H., Smith, B.V. and Price, R.G. (1990)

VRA-GlcNAc: Novel substrate for N-acetyl-ß-D-glucosaminidase applied to assay of this enzyme in urine. Clin. Chem., 36, 1884-1888. [PAJ]

Pocsi I, Csathy L, Olah V A, Price R G. (1991)

Assay of N-acetyl-ß-D-glucosaminidase in neonate urine: comparison of two new colorimetric methods using MNP-GlcNAc and VRA-GlcNAc as substrates. Ann Clin Chem. 29, 292-295. [PAJ]

Pocsi I, Csathy L, Olah V A and Price R G (1992)

Assay of N-acetyl-ß-D-glucosaminidase in urine from neonate: comparison of two new colorimetric methods using MNP-GlcNAc and VRA-GlcNAc as substrates. Ann Clin. Biochem. 29, 292-295. [PAJ]

Dewji NN, De Keyser DR and Stirling JL (1986)

Purification and characterization of b -N-acetylhexosaminidase I2 form from human liver. Biochem. J. 234, 157-162.

Robinson D and Stirling JL (1968)

N-Acetyl-b -D-glucosaminidase in human Spleen. Biochem J. 107, 321-327.

Swallow DM, Stokes DC, Corney C and Harris H (1974)

Differences between the N-acetyl Hexosaminidase isoenzymes in serum and tissues. Ann. Hum. Genet. London 37, 287-302.

Microbiology

Mycoplasma

Khan L, Richardson AC, Price RG, Nicholas R and Miles R (2000)

A chromogenic substrate for the rapid detection of Mycoplasma agalactiae and Mycoplasma bovis. 13th Congress of the International Organisation for Mycoplasmology (Abstract) P-L21.

Salmonella

Cooke VM, Miles RJ, Price RG and Richardson AC (1999)

A novel chromogenic ester agar medium for the detection of Salmonellae. Applied & Environmental Microbiology, 65: 807-812.

Candida

Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W and Richardson AC (2002)

A new chromogenic medium for the detection of Candida Spp. Applied and Environmental Microbiology 68: 3622-3627.

Microbiology General

Paffard SM, Miles R J, Clark C R and Price R G (1997)

Amplified Enzyme-Linked-Immunofilter assays (ELIFAs) enable detection of 5 - 105 Bacterial cells within One hour. Analyt. Biochem. 248, 265-268.

Sanchez-Bernal C S, Robinson G, Miles R J and Price R G (1994)

Development of a sensitive and quantitative enzyme-linked immunofilter assay (ELIFA) for whole bacterial cells. J. Microbiol. Meth. 19, 135-143.

Paffard S M, Miles R J, Clark C R and Price R G (1996)

A sensitive forty minute enzyme linked immunofilter assay (ELIFA) for whole bacterial cells. J. Immunol. Meth. 192., 133-136.

Substrates

General

Aamlid, K H, Lee, G, Price, R G, Richardson, A C, Smith, B V and Taylor S A (1989)

Development of improved chromogenic substrates for the detection and assay of hydrolytic enzymes. Chem & Ind., 106-108.

Aamlid, K. H., Lee, G., Smith, B.V., Richardson, A.C. and Price, R.G. (1990)

New colorimetric substrates for the assay of glycosidases. Carbohydrate Res., 205, C5-C9.

Posci, I., Taylor, S.A., Richardson, A.C., Aamlid, K.H., Smith, B.V. and Price, R.G. (1990)

VRA-GlcNAc: Novel substrate for N-acetyl-ß-D-glucosaminidase applied to assay of this enzyme in urine. Clin. Chem., 36, 1884-1888.

Galactosidase Substrates

Pocsi I, Taylor S A, Richardson A C, Smith B V and Price R G. (1993)

Comparison of several new galactosides as substrates for various ß-D-Galactosidases. (1992) Biochim Biophys Acta., 1163, 54-60.

Bainbridge, B.W., Mathias, N., Price, R.G., Richardson, A.C., Sandhu, J. and Smith, B.V. (1991)

mproved method for the detection of ß-galactosidase activity in colonies of Escherichia coli using a New chromogenic substrate. FEMS Microbiological Lett. 80, 319-324.

Esterases/lipases

Yuen, C-T, Price, R G, Richardson, A C and Praill, P F G (1981)

The assay of arylsterase in serum using two new colorimetric substrates, w-nitrostyrylacetate and propionate. Clin. Chim. Acta 112, 99-105.

Miles R J, Siu E L T, Carrington C, Richardson A C, Smith B V, Price R G (1992)

The detection of Lipase activity in Bacteria using Novel substrates. FEMS Microbiological Lett. 90, 283-288.

Biomarkers

Price RG (2000)

Urinalysis to exclude and monitor nephrotoxicity. Clin. Chim. Acta 297, 173-182.

Whiting PH and Price RG (2001)

Importance of early detection of renal dysfunction: value of markers of early renal disease and damage. Clinical Biochemistry: 3(1), 3-8

Olah AC, Price RG, Csathy L, Orszagh E, Olah E and Varga J (2004)

Age dependence of serum ß-N-acetylhexosaminidase (NAG). Clin. Chem. Lab. Med. 42: 305-306.

Coca SG, Yalavarthy R, Concato J and Parikh CR (2008)

Biomarkers for the diagnosis and risk stratification of cutee kidney injury: A systematic review.

Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P and Bonventre JV (2008)

Urinary biomarkers in the early diagnosis od acute kidney injury. Kidney international 73:863-869.

Hart SGE (2005)

Assessment of renal injury in vivo. J. Pharmacological. and Toxicological. Methods, 52:30-45.

Diphencyprone

Buckley DA, Keane FM, Munn SE, Fuller LC, Higgins EM and du Vivier AWP (1999)

Recalcitrant warts treated by diphencyprone immunotherapy. British Journal of Dermatology 141:292-296.

Damian DL and Johnson JF (2007)

Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone. J Am Acad Dermatol 56: 869-871.

Happle R (2002)

Diphencyprone for the treatment of Alopaecia areata, more data and new aspects [Editorial]. Arch Dermatol 138:1123-113.

Hoffmann R, Wenzel E, Huth A van der Steen P, Schaufel M, Henninger HP and Happle R. (1994)

Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone.  J. Invest Dermatol 103: 530-533.

Higgins E and du Vivier A (2002)

Topical immunotherapy: Unapproved uses, dosages or indications. Clinics in dermatology 20:515-521.

Martindale (2009)

The complete Drug Reference, Dermatological Drugs and sunscreens, Diphencyprone (Sweetman S, Ed) London Pharmaceutical Press., 35th Edition.

Sterling JC, Handfield-Jones S and Hudson PM (2000)

Guidelines for the management of cutaneous warts. Brit. J. dermatology 144:4-11.

Trefzer U and Sterry W (2005)

Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.  Dermatology 211:370-371.

 

DIAGNOSTICS - SUBSTRATES - CHEMICALS - CHROMOGENIC MEDIA - CONSULTANCY